New Targets = Better Standard of Care

Alexander Bastian
Video Categories: Targeted Therapies

Alexander Bastian mentions that looking at more defined populations and leveraging the power of targeted medicine is improving the standard of care.

October 28, 2014

Success of Cytoreductive Therapy

Listen as Dr. Mesa presents his opinion on the success of cytoreductive therapy with patients with polycythemia vera. Supported through funding from Incyte

January 13, 2015

Benefits of Breast Cancer Index

Dr Stephen C. Malamud and Dr Susan K. Boolbol consider the clinical utility of the Breast Cancer IndexSM (BCI) as a test that separates those patients who are more likely to benefit from those who are unlikely to benefit from extended endocrine therapy.